Neutralizing antibodies and lymphocyte count as biomarkers in patients receiving oncolytic adenovirus TILT-123 and adoptive cell transfer of tumor-infiltrating lymphocytes for metastatic melanoma refractory to immune checkpoint inhibitors.

Authors: Lyna Haybout, James Clubb, Tine Monberg, Santeri Pakola, Benedetta Albieri, Susanna Juteau, Eva Ellebaek, Marco Donia, Victor Arias, Tatiana Kudling, Amir Khammari, Claudia Kistler, Suvi Sorsa, Elise Jirovec, Dafne Carolina Alves Quixabeira, Joao Manuel Santos, Victor Cervera, Brigitte Dreno, Inge Marie Svane, Akseli Hemminki

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.9518

Source: Full article


Abstract

9518